Skip to main content
Top
Published in: Arthritis Research & Therapy 1/2024

Open Access 01-12-2024 | Biomarkers | Research

Deregulation in adult IgA vasculitis skin as the basis for the discovery of novel serum biomarkers

Authors: Matija Bajželj, Matjaž Hladnik, Rok Blagus, Vesna Jurčić, Ana Markež, Tanya Deniz Toluay, Snežna Sodin-Šemrl, Alojzija Hočevar, Katja Lakota

Published in: Arthritis Research & Therapy | Issue 1/2024

Login to get access

Abstract

Introduction

Immunoglobulin A vasculitis (IgAV) in adults has a variable disease course, with patients often developing gastrointestinal and renal involvement and thus contributing to higher mortality. Due to understudied molecular mechanisms in IgAV currently used biomarkers for IgAV visceral involvement are largely lacking. Our aim was to search for potential serum biomarkers based on the skin transcriptomic signature.

Methods

RNA sequencing analysis was conducted on skin biopsies collected from 6 treatment-naïve patients (3 skin only and 3 renal involvement) and 3 healthy controls (HC) to get insight into deregulated processes at the transcriptomic level. 15 analytes were selected and measured based on the transcriptome analysis (adiponectin, lipopolysaccharide binding protein (LBP), matrix metalloproteinase-1 (MMP1), C-C motif chemokine ligand (CCL) 19, kallikrein-5, CCL3, leptin, C-X-C motif chemokine ligand (CXCL) 5, osteopontin, interleukin (IL)-15, CXCL10, angiopoietin-like 4 (ANGPTL4), SERPIN A12/vaspin, IL-18 and fatty acid-binding protein 4 (FABP4)) in sera of 59 IgAV and 22 HC. Machine learning was used to assess the ability of the analytes to predict IgAV and its organ involvement.

Results

Based on the gene expression levels in the skin, we were able to differentiate between IgAV patients and HC using principal component analysis (PCA) and a sample-to-sample distance matrix. Differential expression analysis revealed 49 differentially expressed genes (DEGs) in all IgAV patient’s vs. HC. Patients with renal involvement had more DEGs than patients with skin involvement only (507 vs. 46 DEGs) as compared to HC, suggesting different skin signatures. Major dysregulated processes in patients with renal involvement were lipid metabolism, acute inflammatory response, and extracellular matrix (ECM)-related processes. 11 of 15 analytes selected based on affected processes in IgAV skin (osteopontin, LBP, ANGPTL4, IL-15, FABP4, CCL19, kallikrein-5, CCL3, leptin, IL-18 and MMP1) were significantly higher (p-adj < 0.05) in IgAV serum as compared to HC. Prediction models utilizing measured analytes showed high potential for predicting adult IgAV.

Conclusion

Skin transcriptomic data revealed deregulations in lipid metabolism and acute inflammatory response, reflected also in serum analyte measurements. LBP, among others, could serve as a potential biomarker of renal complications, while adiponectin and CXCL10 could indicate gastrointestinal involvement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel Hill Consensus Conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.CrossRefPubMed Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel Hill Consensus Conference nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11.CrossRefPubMed
2.
go back to reference Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schönlein Purpura: A literature review. Acta Derm Venereol. 2017;97(10):1160–6.CrossRefPubMed Hetland LE, Susrud KS, Lindahl KH, Bygum A. Henoch-Schönlein Purpura: A literature review. Acta Derm Venereol. 2017;97(10):1160–6.CrossRefPubMed
3.
go back to reference Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56(1):3–23.CrossRefPubMed Carlson JA. The histological assessment of cutaneous vasculitis. Histopathology. 2010;56(1):3–23.CrossRefPubMed
4.
go back to reference Hočevar A, Tomšič M, Pižem J, Bolha L, Sodin-Šemrl S, Glavač D. MicroRNA expression in the affected skin of adult patients with IgA vasculitis. Clin Rheumatol. 2019;38(2):339–45.CrossRefPubMed Hočevar A, Tomšič M, Pižem J, Bolha L, Sodin-Šemrl S, Glavač D. MicroRNA expression in the affected skin of adult patients with IgA vasculitis. Clin Rheumatol. 2019;38(2):339–45.CrossRefPubMed
5.
go back to reference Jurčić VBL, Matjašič A, Sedej I, Dolinar A, Grubelnik G, Hauptman N, Pižem J, Jevšinek-Skok D, Hočevar A, Ravnik-Glavač M, Glavač D. Association between histopathological changes and expression of selected microRNAs in skin of adult patients with IgA vasculitis. Histopathology. 2019;75(5):683–93.CrossRefPubMed Jurčić VBL, Matjašič A, Sedej I, Dolinar A, Grubelnik G, Hauptman N, Pižem J, Jevšinek-Skok D, Hočevar A, Ravnik-Glavač M, Glavač D. Association between histopathological changes and expression of selected microRNAs in skin of adult patients with IgA vasculitis. Histopathology. 2019;75(5):683–93.CrossRefPubMed
6.
go back to reference Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge. Curr Opin Rheumatol. 2013;25(2):171–8.CrossRefPubMed Piram M, Mahr A. Epidemiology of immunoglobulin A vasculitis (Henoch-Schonlein): current state of knowledge. Curr Opin Rheumatol. 2013;25(2):171–8.CrossRefPubMed
7.
go back to reference Audemard-Verger APE, Baldolli A, Gouellec NL, Augusto JF, Jourde-Chiche N, Raffray L, Thervet E, Deroux A, Goutte J, Hummel A, Lioger B, Sanges S, Cacoub P, Amoura Z, Moulis G, Maurier F, Lavigne C, Urbanski G, Chanal J, Faguer S, Deriaz S, Feirreira-Maldent N, Diot E, Maillot F, Guillevin L, Terrier B. Impact of aging on phenotype and prognosis in IgA vasculitis. Rheumatology (Oxford). 2021;60(9):4245–51.CrossRefPubMed Audemard-Verger APE, Baldolli A, Gouellec NL, Augusto JF, Jourde-Chiche N, Raffray L, Thervet E, Deroux A, Goutte J, Hummel A, Lioger B, Sanges S, Cacoub P, Amoura Z, Moulis G, Maurier F, Lavigne C, Urbanski G, Chanal J, Faguer S, Deriaz S, Feirreira-Maldent N, Diot E, Maillot F, Guillevin L, Terrier B. Impact of aging on phenotype and prognosis in IgA vasculitis. Rheumatology (Oxford). 2021;60(9):4245–51.CrossRefPubMed
8.
go back to reference Hocevar A, Tomsic M, Jurcic V, Perdan Pirkmajer K, Rotar Z. Predicting gastrointestinal and renal involvement in adult IgA vasculitis. Arthritis Res Therapy. 2019;21(1):302.CrossRef Hocevar A, Tomsic M, Jurcic V, Perdan Pirkmajer K, Rotar Z. Predicting gastrointestinal and renal involvement in adult IgA vasculitis. Arthritis Res Therapy. 2019;21(1):302.CrossRef
9.
go back to reference Kuret T, Lakota K, Zigon P, Ogric M, Sodin-Semrl S, Cucnik S, et al. Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis. Clin Rheumatol. 2019;38(2):331–8.CrossRefPubMed Kuret T, Lakota K, Zigon P, Ogric M, Sodin-Semrl S, Cucnik S, et al. Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis. Clin Rheumatol. 2019;38(2):331–8.CrossRefPubMed
10.
go back to reference Kawakami T, Watabe H, Mizoguchi M, Soma Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol. 2006;155(5):983–7.CrossRefPubMed Kawakami T, Watabe H, Mizoguchi M, Soma Y. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol. 2006;155(5):983–7.CrossRefPubMed
11.
go back to reference Delapierre A, Terrier B, Pillebout E, Baudart P, Jourde-Chiche N, Lioger B, et al. Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement. Clin Rheumatol. 2022;41(5):1483–91.CrossRefPubMed Delapierre A, Terrier B, Pillebout E, Baudart P, Jourde-Chiche N, Lioger B, et al. Clinical phenotype and cytokine profile of adult IgA vasculitis with joint involvement. Clin Rheumatol. 2022;41(5):1483–91.CrossRefPubMed
12.
go back to reference Audemard-Verger A, Pillebout E, Jamin A, Berthelot L, Aufray C, Martin B, et al. Recruitment of CXCR3(+) T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity. J Autoimmun. 2019;99:73–80.CrossRefPubMed Audemard-Verger A, Pillebout E, Jamin A, Berthelot L, Aufray C, Martin B, et al. Recruitment of CXCR3(+) T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity. J Autoimmun. 2019;99:73–80.CrossRefPubMed
13.
go back to reference Hočevar A, Rotar Ž, Jurčić V, Čučnik S, Tomšič M. Patient age, gender and extent of purpura may suggest short-term outcomes in adults with IgA vasculitis. Rheumatology (Oxford). 2015;54(7):1330–2.CrossRefPubMed Hočevar A, Rotar Ž, Jurčić V, Čučnik S, Tomšič M. Patient age, gender and extent of purpura may suggest short-term outcomes in adults with IgA vasculitis. Rheumatology (Oxford). 2015;54(7):1330–2.CrossRefPubMed
14.
go back to reference Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798–806.CrossRefPubMed Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798–806.CrossRefPubMed
15.
go back to reference Zhu A, Ibrahim JG, Love MI. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics. 2018;35(12):2084–92.CrossRefPubMedCentral Zhu A, Ibrahim JG, Love MI. Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences. Bioinformatics. 2018;35(12):2084–92.CrossRefPubMedCentral
16.
go back to reference Blagus R, Lusa L. Gradient boosting for high-dimensional prediction of rare events. Comput Stat Data Anal. 2017;113:19–37.CrossRef Blagus R, Lusa L. Gradient boosting for high-dimensional prediction of rare events. Comput Stat Data Anal. 2017;113:19–37.CrossRef
19.
go back to reference Qin J, Zhang L, Ke B, Liu T, Kong C, Jin C. Causal relationships between circulating inflammatory factors and IgA vasculitis: a bidirectional mendelian randomization study. Front Immunol. 2023;14. Qin J, Zhang L, Ke B, Liu T, Kong C, Jin C. Causal relationships between circulating inflammatory factors and IgA vasculitis: a bidirectional mendelian randomization study. Front Immunol. 2023;14.
20.
go back to reference Zhong Z, Tan J, Tan L, Tang Y, Qiu Z, Pei G, et al. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population. Int Immunopharmacol. 2020;89Pt B:107085.CrossRef Zhong Z, Tan J, Tan L, Tang Y, Qiu Z, Pei G, et al. Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population. Int Immunopharmacol. 2020;89Pt B:107085.CrossRef
21.
go back to reference Ding PH, Jin LJ. The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health. J Periodontal Res. 2014;49(1):1–9.CrossRefPubMed Ding PH, Jin LJ. The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health. J Periodontal Res. 2014;49(1):1–9.CrossRefPubMed
22.
go back to reference Fang H, Hua C, Weiss S, Liu A, Cheng W, Claus R, et al. Modulation of Innate immunity by G-CSF and inflammatory response by LBPK95A improves the outcome of Sepsis in a rat model. J Immunol Res. 2018;2018:6085095.CrossRefPubMedPubMedCentral Fang H, Hua C, Weiss S, Liu A, Cheng W, Claus R, et al. Modulation of Innate immunity by G-CSF and inflammatory response by LBPK95A improves the outcome of Sepsis in a rat model. J Immunol Res. 2018;2018:6085095.CrossRefPubMedPubMedCentral
23.
go back to reference Chen X-Q, Tu L, Tang Q, Huang L, Qin Y-H. An emerging role for Neutrophil Extracellular traps in IgA Vasculitis: a Mini-review. Front Immunol. 2022;13. Chen X-Q, Tu L, Tang Q, Huang L, Qin Y-H. An emerging role for Neutrophil Extracellular traps in IgA Vasculitis: a Mini-review. Front Immunol. 2022;13.
24.
go back to reference Patidar M, Yadav N, Dalai SK. Interleukin 15: a key cytokine for immunotherapy. Cytokine Growth Factor Rev. 2016;31:49–59.CrossRefPubMed Patidar M, Yadav N, Dalai SK. Interleukin 15: a key cytokine for immunotherapy. Cytokine Growth Factor Rev. 2016;31:49–59.CrossRefPubMed
25.
go back to reference Yang YL, Li XF, Song B, Wu S, Wu YY, Huang C, et al. The role of CCL3 in the pathogenesis of rheumatoid arthritis. Rheumatol Ther. 2023;10(4):793–808.CrossRefPubMedPubMedCentral Yang YL, Li XF, Song B, Wu S, Wu YY, Huang C, et al. The role of CCL3 in the pathogenesis of rheumatoid arthritis. Rheumatol Ther. 2023;10(4):793–808.CrossRefPubMedPubMedCentral
26.
go back to reference Enocsson H, Wetterö J, Eloranta ML, Gullstrand B, Svanberg C, Larsson M, et al. Comparison of surrogate markers of the type I Interferon Response and their ability to Mirror Disease activity in systemic Lupus Erythematosus. Front Immunol. 2021;12:688753.CrossRefPubMedPubMedCentral Enocsson H, Wetterö J, Eloranta ML, Gullstrand B, Svanberg C, Larsson M, et al. Comparison of surrogate markers of the type I Interferon Response and their ability to Mirror Disease activity in systemic Lupus Erythematosus. Front Immunol. 2021;12:688753.CrossRefPubMedPubMedCentral
27.
go back to reference Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum. 2009;60(10):3098–107.CrossRefPubMedPubMedCentral Bauer JW, Petri M, Batliwalla FM, Koeuth T, Wilson J, Slattery C, et al. Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study. Arthritis Rheum. 2009;60(10):3098–107.CrossRefPubMedPubMedCentral
28.
go back to reference Kovács D, Fazekas F, Oláh A, Törőcsik D. Adipokines in the skin and in Dermatological diseases. Int J Mol Sci. 2020;21(23). Kovács D, Fazekas F, Oláh A, Törőcsik D. Adipokines in the skin and in Dermatological diseases. Int J Mol Sci. 2020;21(23).
29.
go back to reference Gibson MS, Domingues N, Vieira OV. Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis. Front Physiol. 2018;9:654.CrossRefPubMedPubMedCentral Gibson MS, Domingues N, Vieira OV. Lipid and non-lipid factors affecting macrophage dysfunction and inflammation in atherosclerosis. Front Physiol. 2018;9:654.CrossRefPubMedPubMedCentral
30.
31.
go back to reference Gariballa S, Alkaabi J, Yasin J, Al Essa A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disorders. 2019;19(1):55.CrossRef Gariballa S, Alkaabi J, Yasin J, Al Essa A. Total adiponectin in overweight and obese subjects and its response to visceral fat loss. BMC Endocr Disorders. 2019;19(1):55.CrossRef
32.
go back to reference Brezovec N, Perdan-Pirkmajer K, Čučnik S, Sodin-Šemrl S, Varga J, Lakota K. Adiponectin Deregulation in systemic Autoimmune Rheumatic diseases. Int J Mol Sci. 2021;22(8). Brezovec N, Perdan-Pirkmajer K, Čučnik S, Sodin-Šemrl S, Varga J, Lakota K. Adiponectin Deregulation in systemic Autoimmune Rheumatic diseases. Int J Mol Sci. 2021;22(8).
Metadata
Title
Deregulation in adult IgA vasculitis skin as the basis for the discovery of novel serum biomarkers
Authors
Matija Bajželj
Matjaž Hladnik
Rok Blagus
Vesna Jurčić
Ana Markež
Tanya Deniz Toluay
Snežna Sodin-Šemrl
Alojzija Hočevar
Katja Lakota
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 1/2024
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/s13075-024-03317-6

Other articles of this Issue 1/2024

Arthritis Research & Therapy 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.